|
|
 |
AMMONIUM GLYCYRRHIZATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADASUVE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AIRSUPRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADVIL ALLERGY SINUS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADDYI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|